197 related articles for article (PubMed ID: 23120659)
1. Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis.
Sudhakara Rao M; Dwarakanatha Reddy D; Murthy PS
Indian J Otolaryngol Head Neck Surg; 2009 Dec; 61(4):320-32. PubMed ID: 23120659
[TBL] [Abstract][Full Text] [Related]
2. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
Picado C
Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
[TBL] [Abstract][Full Text] [Related]
3. Rupatadine in allergic rhinitis and chronic urticaria.
Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
[TBL] [Abstract][Full Text] [Related]
4. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
6. Rupatadine: a review of its use in the management of allergic disorders.
Keam SJ; Plosker GL
Drugs; 2007; 67(3):457-74. PubMed ID: 17335300
[TBL] [Abstract][Full Text] [Related]
7. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Izquierdo I; Merlos M; García-Rafanell J
Drugs Today (Barc); 2003 Jun; 39(6):451-68. PubMed ID: 12944997
[TBL] [Abstract][Full Text] [Related]
8. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Martínez-Cócera C; De Molina M; Martí-Guadaño E; Pola J; Conde J; Borja J; Pérez I; Arnaiz E; Izquierdo I;
J Investig Allergol Clin Immunol; 2005; 15(1):22-9. PubMed ID: 15864879
[TBL] [Abstract][Full Text] [Related]
9. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
González-Núñez V; Bachert C; Mullol J
Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
[TBL] [Abstract][Full Text] [Related]
10. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
Katiyar S; Prakash S
Prim Care Respir J; 2009 Jun; 18(2):57-68. PubMed ID: 18695846
[TBL] [Abstract][Full Text] [Related]
12. Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects.
Shamizadeh S; Brockow K; Ring J
Allergo J Int; 2014; 23(3):87-95. PubMed ID: 26120520
[TBL] [Abstract][Full Text] [Related]
13. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Okubo K; Suzuki T; Tanaka A; Aoki H
Allergol Int; 2019 Apr; 68(2):207-215. PubMed ID: 30391169
[TBL] [Abstract][Full Text] [Related]
15. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
16. Effects of second-generation H1-antihistamine drugs on angiogenesis in
Duman N; Duman R; Vurmaz A
Cutan Ocul Toxicol; 2023 Mar; 42(1):8-11. PubMed ID: 36469932
[TBL] [Abstract][Full Text] [Related]
17. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
[TBL] [Abstract][Full Text] [Related]
18. Rupatadine relieves allergic rhinitis: a prospective observational study.
Eloy P; Tobback L; Imschoot J
B-ENT; 2015; 11(1):11-8. PubMed ID: 26513942
[TBL] [Abstract][Full Text] [Related]
19. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Maiti R; Rahman J; Jaida J; Allala U; Palani A
Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
[TBL] [Abstract][Full Text] [Related]
20. H1-antihistamines for chronic spontaneous urticaria.
Sharma M; Bennett C; Cohen SN; Carter B
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]